Monday, October 05, 2015 6:43:59 AM
Pivotal P2Bs in the Cancer sector are badly needed and come after considerable years of many deaths using the Chemo, Radiation, Surgery therapies that are essentially failure to arrest Cancers for most persons. Personally I have lost family members and friends to such therapies.
Immunotherapies are making advances now only in the last 12 months thru the approvals of BMS and MRK new drugs. In $ONCS Combo case the FDA simply wanted more time and info before allowing the trial to go forth.
$ONCS 41 person Combo trial is now in full operation.
https://clinicaltrials.gov/ct2/show/NCT02493361?term=UCSF+and+keytruda&rank=2
What is amazing is that the UCSF has taken on full sponsorship of this expected $2 to 3 millions cost over the 2 years projected duration.
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM